Home
Leadership
Policy Areas
Resources
News
09.27.23
New Bill Protects Continued Development for Rare Disease Medicines
Read more
News
02.28.23
RDCC Participates in FDA Rare Disease Day 2023 Public Meeting
Read more
News
01.20.23
Hopes, Fears for Orphan Drug Act
Read more
News
12.08.22
Vital Health Podcast: The Accelerated Approval Pathway is Vital for Rare Disease Treatments
Read more
News
11.28.22
RARECast Podcast: Examining the Legislative Landscape for Rare Disease Drug Development
Read more
News
11.22.22
Groups Hope New Congress Will Pass Bipartisan Bills Centered on Rare Diseases
Read more
News
11.15.22
New Study Finds Patient Access to Rare Disease Drugs Would Decline Sharply Under Proposals to Limit Medicaid Reimbursements
Read more
News
10.12.22
RDCC Joins in Call for Repeal of R&D Tax Policy that Hurts Rare Disease Innovation
Read more
News
09.12.22
RDCC Joins in Support of “Newborn Screening Saves Lives Reauthorization Act of 2021” in Letter to Senate Leaders
Read more
News
02.07.22
RDCC Advocates for “Newborn Screening Saves Lives Reauthorization Act of 2021” in Letter to Congressional Leaders
Read more
News
12.29.21
Cutting the Orphan Drug Tax Credit is Not Drug Pricing Reform
Read more
News
08.03.21
Rare Disease Drugmakers to Congress: Don’t Gut the Accelerated Approval Pathway
Read more
News
08.03.21
Drug Makers To Congress: Reject Accelerated Approval Pay Reforms
Read more
News
05.13.21
Rare Disease Companies Unite to Advocate for Life-Changing Therapies
Read more